Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Fleischer

Showing results (391-400 of 569) with videos related to

Pageof 57
Sort By:
Journal of Drugs in Dermatology : JDD|March 22, 2005
Prescribing patterns for topical retinoids within NAMCS dataRajesh Balkrishnan, Julia C Sansbury, Rahul A Shenolikar, et al.
Pediatric Dermatology|November 10, 2020
Comparing prescribing patterns for topical corticosteroids based on their FDA indication by ageMegan E Freeze, Esther A Balogh, Abigail Cline, et al.
International Immunology|April 28, 2000
Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shiftA Doetze, J Satoguina, G Burchard, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Salmonella-reactive synovial fluid T-cell clones in a patient with post-infectious Salmonella arthritisE Hermann, W J Mayet, T Poralla, et al.
Kidney International|August 1, 1993
T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathwayM Girndt, H Köhler, E Schiedhelm-Weick, et al.
International Immunology|September 1, 2000
Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cellsS O Cramer, C Trumpfheller, U Mehlhoop, et al.
Scandinavian Journal of Immunology|February 1, 1994
Differential effects of IL-10 on proliferation and cytokine production of human gamma/delta and alpha/beta T cellsJ F Schlaak, E Hermann, H Gallati, et al.
The American Journal of Managed Care|August 19, 2003
Analysis of factors associated with increased prescription illegibility: results from the National Ambulatory Medical Care Survey, 1990-1998Aditya K Gupta, Elizabeth A Cooper, Steven R Feldman, et al.
The Journal of Dermatological Treatment|January 24, 2006
Infliximab for inpatient psoriasis management--is there a role?Andrew A Nelson, Daniel J Pearce, Alan B Fleischer, et al.
International Journal of Dermatology|May 3, 2006
Psoriasis treatment in the United States at the end of the 20th centuryDaniel J Pearce, Katherine H Stealey, Rajesh Balkrishnan, et al.
Pageof 57

Showing results (391-400 of 569) with videos related to

Sort By:
Pageof 57
Journal of Drugs in Dermatology : JDD|March 22, 2005
Prescribing patterns for topical retinoids within NAMCS dataRajesh Balkrishnan, Julia C Sansbury, Rahul A Shenolikar, et al.
Pediatric Dermatology|November 10, 2020
Comparing prescribing patterns for topical corticosteroids based on their FDA indication by ageMegan E Freeze, Esther A Balogh, Abigail Cline, et al.
International Immunology|April 28, 2000
Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shiftA Doetze, J Satoguina, G Burchard, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Salmonella-reactive synovial fluid T-cell clones in a patient with post-infectious Salmonella arthritisE Hermann, W J Mayet, T Poralla, et al.
Kidney International|August 1, 1993
T cell activation defect in hemodialysis patients: evidence for a role of the B7/CD28 pathwayM Girndt, H Köhler, E Schiedhelm-Weick, et al.
International Immunology|September 1, 2000
Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cellsS O Cramer, C Trumpfheller, U Mehlhoop, et al.
Scandinavian Journal of Immunology|February 1, 1994
Differential effects of IL-10 on proliferation and cytokine production of human gamma/delta and alpha/beta T cellsJ F Schlaak, E Hermann, H Gallati, et al.
The American Journal of Managed Care|August 19, 2003
Analysis of factors associated with increased prescription illegibility: results from the National Ambulatory Medical Care Survey, 1990-1998Aditya K Gupta, Elizabeth A Cooper, Steven R Feldman, et al.
The Journal of Dermatological Treatment|January 24, 2006
Infliximab for inpatient psoriasis management--is there a role?Andrew A Nelson, Daniel J Pearce, Alan B Fleischer, et al.
International Journal of Dermatology|May 3, 2006
Psoriasis treatment in the United States at the end of the 20th centuryDaniel J Pearce, Katherine H Stealey, Rajesh Balkrishnan, et al.
Pageof 57